Philippines - English - FDA (Food And Drug Administration)

new myrex laboratories, inc. - drug - clindamycin (as hydrochloride) - clin-gen

Philippines - English - FDA (Food And Drug Administration)

scheele laboratories phils., inc. - drug - doxycycline (as hyclate) - doxalin

Philippines - English - FDA (Food And Drug Administration)

new myrex laboratories, inc. - drug - clindamycin (as hydrochloride) - clin-gen

Philippines - English - FDA (Food And Drug Administration)

new myrex laboratories, inc. - drug - clindamycin (as hydrochloride) - kylezine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ldp laboratorios torlan s.a. - cefepime dihydrochloride monohydrate 1189,14 mg - eq. cefepime 1000 mg - powder for solution for injection/infusion - 1000 mg - cefepime dihydrochloride monohydrate 1189.14 mg - cefepime

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ldp laboratorios torlan s.a. - cefepime dihydrochloride monohydrate 2378,28 mg - eq. cefepime 2000 mg - powder for solution for injection/infusion - 2000 mg - cefepime dihydrochloride monohydrate 2378.28 mg - cefepime

European Union - English - EMA (European Medicines Agency)

nova laboratories ireland limited - 6-mercaptopurine monohydrate - leukemia, lymphoid - antineoplastic agents - xaluprine is indicated for the treatment of acute lymphoblastic leukaemia (all) in adults, adolescents and children.

Philippines - English - FDA (Food And Drug Administration)

scheele laboratories phils., inc. - drug - doxycycline (as hyclate) - none

Ireland - English - HPRA (Health Products Regulatory Authority)

laboratorios liconsa, s.a. - terbinafine - tablets - 250 milligram - antifungals for systemic use - antifungals for systemic use - it is indicated in the treatment of the following skin and nail fungal infections: treatment of tinea corporis, tinea cruris and tinea pedis, when oral therapy is considered appropriate depending on the site, severity or extent of the infection and for the treatment of onychomycosis caused by dermatophytes

Australia - English - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - triclosan, quantity: 10 mg/ml - application - excipient ingredients: edetate sodium; methyl hydroxybenzoate; dibasic sodium phosphate; purified water; citric acid; ethanol; sodium lauryl sulfate; fragrance (perfume); glycerol; cocamide dea; coconut oil; diethanolamine - a foaming emolient antiseptic soap for pre-operative washing to cleanse and disinfect the skin.